Medical technology sector raises fresh concerns with Labor’s capital gains tax overhaul
Australian medical technology industry groups are protesting new federal budget changes, specifically a 10-year limit on R&D tax incentive refunds. They argue these policies will hinder the commercialization of new health products, which often require long development cycles.
Why it matters
The dispute highlights the tension between government fiscal policy and the need to support high-risk, long-term innovation in the life sciences sector.
The sector says changes to eligibility elements of refundable research and development, among other elements, are a threat to business. ( ABC News: Maren Preuss )
The article presents the industry's concerns while acknowledging the government's legislative process, maintaining a balanced reporting style.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in